Royal Bank Of Canada Mirum Pharmaceuticals, Inc. Transaction History
Royal Bank Of Canada
- $479 Billion
- Q4 2024
A detailed history of Royal Bank Of Canada transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 10,509 shares of MIRM stock, worth $553,824. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,509
Previous 27,216
61.39%
Holding current value
$553,824
Previous $1.06 Million
59.1%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$346 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$241 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$171 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$147 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$137 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.94B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...